NRD
MRK icon

Nebula Research & Development’s Merck MRK Stock Holding History

Nebula Research & Development’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,344
Closed -$2.27M – 1091
2024
Q2 		$2.27M Buy
+18,344
New +$2.36M 0.37% 36
2024
Q1 		– Sell
-5,209
Closed -$568K – 902
2023
Q4 		$568K Buy
5,209
+2,318
+80% +$241K 0.17% 211
2023
Q3 		$298K Buy
+2,891
New +$312K 0.16% 277

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nebula Research & Development's MRK Position: Q3 2024 in Review

Nebula Research & Development sold out of Merck (MRK) in Q3 2024, closing a stake of 18,344 shares — an estimated $2.27M sold.

Nebula Research & Development first reported a position in MRK in Q3 2023 and held it in 3 quarters. The position peaked at $2.27M in Q2 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Nebula Research & Development reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Nebula Research & Development sold 18,344 Merck shares in Q3 2024, an estimated $2.27M.
  • Nebula Research & Development first reported a position in Merck in Q3 2023 and held it in 3 quarters.
  • Nebula Research & Development's Merck position peaked at $2.27M in Q2 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.